Stelerix Web Blog Knowledge at your Fingertips

17Feb/110

Report Giveaway – This Week Only!!

It's a $119.00 Value, for free!! We engaged over 1500 industry professionals in India and North America.

Get a thorough picture of what it takes to win in India. Forward it to your friends and get an exclusive mini-report, packed with primary research!

You can check out the Table of Contents, and download the report here!!

Posted by Jeff

15Feb/110

KOL Engagement and Alignment.

Here's a quick excerpt from our Special Comprehensive Country Report, India. It's something we've seen addressed again and again in our follow-up interviews.  I've also thrown in a YouTube interview with Tushar Barad who talks about some of the intricacies of engaging with KOLs.

The updated report will be exclusively available for free through our great friends over at pharmaphorum. So you better get registered!

"Respondents identified active engagement of local Key Opinion Leaders as the most effective means to understand their needs. Further, this strategy provides accurate insight into actual affordability as demonstrated by purchasing power and cost of living, in addition to possible commercial strategies and their respective likelihoods. However, our research also suggested that organizations as a whole have been slow to actively engage end-users. Patience and value on the long term was also a key trend among respondents. It was evident from our results that success in India favors ongoing and long-term relationships that grow and evolve over time. While short-term profit can be made, it is clear that the initial time investment and requisite patience were rewarded many times over when focus was placed on the longer term.  A further benefit of continuous investment in “relationship capital” is the evolution of mutually business partnerships. Organizations who establish themselves effectively in India can often leverage their presence to reach other fast-growing markets in the South-Asian and Asia-Pacific region. Our experts agree that to be effective into 2020 and beyond, market leaders must invest proactively in nascent relationships, given the propensity for longer cycle time in such business partnerships. Opportunity to cut costs and drive access will exist for those who look to partner and aid, rather than exploit."

Posted by Jeff

Oh yeah, the full report will also be available for download here, but this week only!!

10Feb/110

Feature: Swami Samarth Pharmatech

We've got another interview up! Check out our exclusive feature with the owner of Mumbai-based Swami Samarth Pharmatech, Nitin Parab. He talks about what's necessary for success in

We're also hosting the web version of Nitin's upcoming event "Gateway to Europe, for Medical Devices."

We are lucky to have the partners we do.

Posted by Jeff

Posted by Jeff

9Feb/110

A New Paradigm

It can be tough to sit down and watch a 40 minute interview. People don't have time to make dinner, how are they going to have time to watch something so encompassing?

With that in mind, I've begun breaking down my work into bite-size video portions. I'll post them here, and update the pages on the main site concurrently.

In this short clip, my friend Dr. Gregory Weiss talks about a new paradigm in translational medicine and drug development, based on a comprehensive, global, or combinatorial approach. Watch and learn!

Posted by Jeff

1Feb/110

Common Hurdles.

Here in Canada, we often hear about a potentially-crippling void of innovation. Closer inspection indicates that it isn't for lack of research. In fact, it's a sub-par commercialization process that is culpable for the dropped ball.

This is of course a common theme, but I was surprised to hear it mentioned to me by Kiran Mazumdar Shaw, the Managing Director of India's largest biotechnology company, Biocon. "Scientist entrepreneurs are few and far between - what challenges our scientists in advancing their research into businesses?"

And as all our research is guided by primary interactions with stakeholders, so this will be the guiding question, over the course of the next few interviews. Stay tuned for step-by-step examples of entrepreneurs who have commercialized their developments.

28Jan/110

Value-Added Generics

I appreciate your patience in bearing with me in the last few weeks. As you undoubtedly know, I've been busy populating the library section of the main site. I am making a lot of progress, and there is even more in the pipeline.

One of the challenges has been ensuring high-quality audio. Much to my initial dismay, the sound-quality suffered on the first few recordings. For enduring this, I am grateful. After much experimentation I have found a methodology for getting things online relatively quickly and at high-fidelity.

I'm also picking out parts that I thought were of particular value. Here's a clip from Atul Sharma, talking about the importance of innovation in value-added generics.

Posted by Jeff

25Jan/110

Patient Retention and Recruitment

I was lucky enough to catch up with Melynda Geurts, Chief Operating Officer at D. Anderson & Company (DAC). As a leading service provider, the DAC team leverages clinical trial expertise, creative acumen and site management excellence to produce measurable results.

DAC is scheduled to be appearing at a couple of upcoming conferences, so I kept it brief and honed in on the critical things to remember, in terms of effective clinical outsourcing and patient recruitment strategies, like, why it's worth remembering in the first place.

20Jan/110

Exclusive Interview with an Expert: Vikram Sathish Asokan

We've had a lot of luck getting in touch with experts, as of late.

My latest conversation was with sales superstar Vikram Sathish Asokan, a Director at Lister and Berg in India.

We talked about the three pillars to success in start-up companies (spoiler alert: Good human resources capable of getting things done, financing and technological savvy). We also touched on how to transgress beyond selling and ensure profitable long term relationships with Indian clients.

If you have ideas for future interview, or how to improve, I'm really happy to incorporate constructive criticism going forward so please do send!

Posted by Jeff

18Jan/110

Call for Questions.

We have an interview upcoming with Vivek Shukla, later next week.

His 12  years of experience serving over 40 reputable clients in the Indian pharmaceutical industry have given him a grasp of strategic business knowledge that is unrivaled.

Now is your chance to pick the brains of a world-class expert. Comment or send questions to info@stelerix.com

Posted by Jeff

18Jan/110

Exclusive On-Demand Webinar, Free! Atul Sharma – Global Partnerships

If you have not yet read or listened, check this out!

Atul Sharma, Senior Manager at Alembic Limited took some time to speak with me about his expansive experiences in a diverse array of emerging and mature markets.

We discuss a number of issues in-depth, like understanding local success drivers and why innovation is especially important in generic formulations.

There are lots more similar interviews coming up, so submit your questions if you want to hear from experts!

Posted by Jeff

Page 1 of 3123